BR9915270A - Método para prevenir e reverter aterosclerose em mamìferos - Google Patents

Método para prevenir e reverter aterosclerose em mamìferos

Info

Publication number
BR9915270A
BR9915270A BR9915270-3A BR9915270A BR9915270A BR 9915270 A BR9915270 A BR 9915270A BR 9915270 A BR9915270 A BR 9915270A BR 9915270 A BR9915270 A BR 9915270A
Authority
BR
Brazil
Prior art keywords
aliquot
mammal
mammals
prevent
atherosclerosis
Prior art date
Application number
BR9915270-3A
Other languages
English (en)
Inventor
Duncan J Stewart
Original Assignee
Vasogem Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/304,262 external-priority patent/US6264646B1/en
Application filed by Vasogem Ireland Ltd filed Critical Vasogem Ireland Ltd
Publication of BR9915270A publication Critical patent/BR9915270A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0023—Agression treatment or altering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Electrotherapy Devices (AREA)
  • Radiation-Therapy Devices (AREA)

Abstract

"MéTODO PARA PREVENIR E REVERTER ATEROSCLEROSE EM MAMìFEROS". Um método para prevenir a progressão e para causar a regressão de aterosclerose em um mamífero compreende: (a) tratar uma porção de sangue de mamífero ex vivo com pelo menos um elemento causador de temperatura selecionado do grupo que consiste em uma temperatura acima ou abaixo da temperatura corpórea, uma emissão eletromagnética e um ambiente oxidativo; e (b) administrar a porção de sangue tratado na etapa (a) ao mamífero, onde a porção possui um volume suficiente para alcançar uma regressão em uma lesão de aterosclerose existente no mamífero.
BR9915270-3A 1998-11-13 1999-11-15 Método para prevenir e reverter aterosclerose em mamìferos BR9915270A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19023698A 1998-11-13 1998-11-13
US09/304,262 US6264646B1 (en) 1998-11-13 1999-05-06 Method for preventing and reversing atherosclerosis in mammals
PCT/CA1999/001092 WO2000029003A2 (en) 1998-11-13 1999-11-15 Method for preventing and reversing atherosclerosis in mammals

Publications (1)

Publication Number Publication Date
BR9915270A true BR9915270A (pt) 2003-12-30

Family

ID=26885899

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915270-3A BR9915270A (pt) 1998-11-13 1999-11-15 Método para prevenir e reverter aterosclerose em mamìferos

Country Status (16)

Country Link
EP (1) EP1128837B1 (pt)
JP (1) JP2002529510A (pt)
CN (1) CN1230182C (pt)
AT (1) ATE233093T1 (pt)
AU (1) AU768300B2 (pt)
BR (1) BR9915270A (pt)
CA (1) CA2348599A1 (pt)
CZ (1) CZ20011642A3 (pt)
DE (1) DE69905602T2 (pt)
DK (1) DK1128837T3 (pt)
EA (1) EA003421B1 (pt)
ES (1) ES2192885T3 (pt)
MX (1) MXPA01004801A (pt)
NO (1) NO20012311L (pt)
NZ (1) NZ511467A (pt)
WO (1) WO2000029003A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2271190A1 (en) 1999-05-06 2000-11-06 Vasogen Ireland Limited Improved method for treating mammals with modified mammalian blood
US7125897B1 (en) 1999-09-24 2006-10-24 Vasogen Ireland Limited Combined therapies for atherosclerosis treatment
CA2309417A1 (en) * 2000-05-25 2001-11-25 Anthony E. Bolton Apoptotic entities for use in treatment of endothelium dysfunction disorders
WO2005097145A1 (en) * 2004-04-12 2005-10-20 Vasogen Ireland Limited Myocarditis treatment
WO2008000067A1 (en) * 2006-06-26 2008-01-03 Vasogen Ireland Limited Treatment of mild chronic heart failure in human patients
RU2475275C1 (ru) * 2011-08-08 2013-02-20 Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Способ лечения облитерирующего атеросклероза артерий нижних конечностей
RU2475274C1 (ru) * 2011-08-09 2013-02-20 Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Способ лечения атеросклероза артерий нижних конечностей
RU2475276C1 (ru) * 2011-08-09 2013-02-20 Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Способ лечения облитерирующего атеросклероза артерий нижних конечностей

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD249143A3 (de) * 1985-03-20 1987-09-02 Ilmenau Tech Hochschule Vorrichtung zur physiologisch-therapeutisch wirksamen optischen bestrahlung koerpereigenen venenblutes
WO1993015778A1 (en) * 1992-02-07 1993-08-19 Anthony Ernest Bolton Method of inhibiting the aggregation of blood platelets
US5980954A (en) * 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases

Also Published As

Publication number Publication date
WO2000029003A2 (en) 2000-05-25
EA003421B1 (ru) 2003-04-24
NO20012311L (no) 2001-07-02
EP1128837A2 (en) 2001-09-05
WO2000029003A3 (en) 2000-08-31
AU1145000A (en) 2000-06-05
EA200100543A1 (ru) 2001-10-22
ES2192885T3 (es) 2003-10-16
DE69905602T2 (de) 2003-10-09
DK1128837T3 (da) 2003-06-16
AU768300B2 (en) 2003-12-04
EP1128837B1 (en) 2003-02-26
CA2348599A1 (en) 2000-05-25
JP2002529510A (ja) 2002-09-10
ATE233093T1 (de) 2003-03-15
DE69905602D1 (de) 2003-04-03
NZ511467A (en) 2002-12-20
CZ20011642A3 (cs) 2002-06-12
CN1230182C (zh) 2005-12-07
MXPA01004801A (es) 2002-09-18
CN1330549A (zh) 2002-01-09
NO20012311D0 (no) 2001-05-10

Similar Documents

Publication Publication Date Title
DE69923671D1 (de) Verwendung von kannabidiol als entzündunghemmende mittel
ES2192642T3 (es) Producto para el teñido oxidante de fibras de queratina..
EA199800667A1 (ru) Новые фенантридины
IT8519212A0 (it) Riduzione di una lesione arteriosclerotica mediante assorbimento selettivo di energia elettromagnetica in un suo componente.
TR200201822T2 (tr) Konjestif kalp yetmezliğinin ön-tedavi görmüş otolog kan ile tedavi edilmesi.
ES2159309T3 (es) Semillas tratadas.
HN1996000017A (es) Isotiazolonas
BR9915270A (pt) Método para prevenir e reverter aterosclerose em mamìferos
NL1004205A1 (nl) Microgolf oven met verbeterde deur.
UA37199C2 (uk) Алкіламінокетони
PT1092040E (pt) Metodos de inibicao helicobacter pylori
TR199900430T2 (xx) �kameli 1,2,3,4-tetrahidro-2-dibenzofuranaminler ve 2-aminosiklohepta$b] benzofuranlar.
SE9803079D0 (sv) Sätt och anordning vid värmebehandling av kroppsvävnad
DE69840575D1 (de) Optischer wellenleiter mit mikrospiegel, sein herstellungsverfahren, und optischer signalprozessor
BR9304873A (pt) Método para aperfeiçoar um processo enzimático, utilizando pelo menos uma enzima que apresenta atividade pectinase.
ID28174A (id) Turunan 5-imino-13-deoksi antrasiklin, penggunaannya, dan proses pembuatannya
DE3864011D1 (de) Scheibenkupplung.
DE60314123D1 (de) Selektive oxidation mit erhöhter sicherheit
PT1017377E (pt) Utilizacao de 2-aminotetralinas 6,7-substituidas para o tratamento de condicoes inflamatorias mediadas por citoquina
Wolters Heat treatment of lamellar and spheroidal graphite cast iron. II
UA43400C2 (uk) Спосіб підсилення рівня електричного сигналу
ES1027848Y (es) Pestillo con palanca de traccion.
UA30521A (uk) Спосіб лікування доброякісної гіперплазії передміхурової залози у поєднанні з хронічним калькульозним простатитом
IT1274939B (it) Serratura di sicurezza a funzionamento elettrico e manuale
ECSP961804A (es) Nuevos compuestos monociclicos de b -.lactama

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 10 (VIII) DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.